Flaxseed Supplementation Reduces Plasma Lipoprotein(a) Levels: A Meta-Analysis.
Conclusions: This finding highlights the potential clinical significance of flaxseed supplementation for patients who are at risk of a high residual CVD despite intensive statin therapy, patients with hyperliporoteinemia(a), and patients who prefer natural remedies for CVD prevention in the context of a healthy lifestyle. Further RCTs are needed to establish the role of flaxseed-containing products on lowering Lp(a).
PMID: 31634874 [PubMed - as supplied by publisher]
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Sahebkar A, Katsiki N, Ward N, Reiner Ž Tags: Altern Ther Health Med Source Type: research
More News: Alternative and Complementary Therapies | Cardiology | Cardiovascular | Cholesterol | Complementary Medicine | Databases & Libraries | Flaxseed | Heart | Statin Therapy | Study